{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:30:37Z","timestamp":1786984237064,"version":"build-2736575974"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"33","license":[{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100032767","name":"Sichuan Medical Association","doi-asserted-by":"crossref","award":["2025RF30"],"award-info":[{"award-number":["2025RF30"]}],"id":[{"id":"10.13039\/100032767","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8,14]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>To ascertain the median effective dose (ED50) and 95% effective dose (ED95) of a combination of sufentanil and remimazolam for suppressing the tracheal intubation response in patients receiving general anesthesia and to assess the hemodynamic stability and incidence of adverse events related to this drug regimen, this prospective dose-finding study used Dixon\u2019s up-and-down sequential method. Thirty-one patients scheduled for surgery under general anesthesia between October 2023 and December 2023 were assessed for eligibility; 7 were excluded, and 24 completed the dose-finding sequence and were analyzed (12 with a negative and 12 with a positive intubation response). Anesthesia was induced with remimazolam 0.35\u2009mg\/kg, followed by sufentanil at an initial dose of 0.4 \u00b5g\/kg, with subsequent dose adjustments based on the intubation response. The primary endpoint was the ED50 of sufentanil, and secondary endpoints included hemodynamic indices and adverse events. The ED50 and ED95 of sufentanil required to suppress the tracheal intubation response were 0.358 \u00b5g\/kg (95% confidence interval, 0.340\u20130.376 \u00b5g\/kg) and 0.436 \u00b5g\/kg (95% CI, 0.409\u20130.504 \u00b5g\/kg), respectively. Heart rate did not differ significantly between response groups. Mean arterial pressure at T2 and the incidence of hypertension were higher in the positive-response group. When remimazolam 0.35\u2009mg\/kg was used for induction, the ED50 and ED95 of sufentanil for suppressing the tracheal intubation response were 0.358 and 0.436 \u00b5g\/kg, respectively. These estimates should be interpreted within the study population and dose-finding design.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000050209","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:02:42Z","timestamp":1786730562000},"page":"e50209","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Median effective dose of sufentanil combined with remimazolam for suppressing the response to tracheal intubation"],"prefix":"10.1097","volume":"105","author":[{"given":"Qin","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Anesthesiology, Beijing Anzhen Nanchong Hospital of Capital Medical University & Nanchong Central Hospital, Nanchong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yalan","family":"Yong","sequence":"additional","affiliation":[{"name":"Department of Emergency, Beijing Anzhen Nanchong Hospital of Capital Medical University & Nanchong Central Hospital, Nanchong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanhuan","family":"Dai","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Beijing Anzhen Nanchong Hospital of Capital Medical University & Nanchong Central Hospital, Nanchong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gui","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Nanchong Fourth People\u2019s Hospital, Nanchong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7755-6356","authenticated-orcid":false,"given":"Li","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Beijing Anzhen Nanchong Hospital of Capital Medical University & Nanchong Central Hospital, Nanchong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260817","doi-asserted-by":"crossref","first-page":"110287","DOI":"10.1016\/j.jclinane.2021.110287","article-title":"Effect of dexmedetomidine on hemodynamic responses to tracheal intubation: a meta-analysis with meta-regression and trial sequential analysis.","volume":"72","author":"De Cassai","year":"2021","journal-title":"J Clin Anesth"},{"key":"R2-20260817","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.2147\/DDDT.S415872","article-title":"Intravenous lidocaine decreased the median effective concentration of sufentanil for tracheal intubation in obese patients.","volume":"17","author":"Jia","year":"2023","journal-title":"Drug Des Devel Ther"},{"key":"R3-20260817","first-page":"CD004087","article-title":"Pharmacological agents for preventing morbidity associated with the haemodynamic response to tracheal intubation.","volume":"2013","author":"Khan","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"R4-20260817","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1186\/s12871-024-02855-5","article-title":"The median effective dose of ciprofol combined with sufentanil in suppressing the laryngeal mask airway insertion response in both young and older adult patients.","volume":"24","author":"Zhou","year":"2024","journal-title":"BMC Anesthesiol"},{"key":"R5-20260817","doi-asserted-by":"crossref","first-page":"535","DOI":"10.2147\/DDDT.S449200","article-title":"The effects of different doses of sufentanil on intraoperative cardiovascular response and postoperative recovery in patients undergoing cardiac surgery: a retrospective cohort study.","volume":"18","author":"Li","year":"2024","journal-title":"Drug Des Devel Ther"},{"key":"R6-20260817","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/s13019-022-01986-5","article-title":"Sufentanil: a risk factor for lactic acidosis in patients after heart valve surgery.","volume":"17","author":"Zhan","year":"2022","journal-title":"J Cardiothorac Surg"},{"key":"R7-20260817","doi-asserted-by":"crossref","first-page":"111215","DOI":"10.1016\/j.jclinane.2023.111215","article-title":"Opioid-free anesthesia: a systematic review and meta-analysis.","volume":"90","author":"Feenstra","year":"2023","journal-title":"J Clin Anesth"},{"key":"R8-20260817","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/ALN.0000000000004840","article-title":"Opioid-free anesthesia protocol on the early quality of recovery after major Surgery (SOFA trial): a randomized clinical trial.","volume":"140","author":"L\u00e9ger","year":"2024","journal-title":"Anesthesiology"},{"key":"R9-20260817","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s40265-021-01544-8","article-title":"Remimazolam: a review in procedural sedation.","volume":"81","author":"Lee","year":"2021","journal-title":"Drugs"},{"key":"R10-20260817","doi-asserted-by":"crossref","first-page":"690875","DOI":"10.3389\/fphar.2021.690875","article-title":"Remimazolam: non-clinical and clinical profile of a new sedative\/anesthetic agent.","volume":"12","author":"Kilpatrick","year":"2021","journal-title":"Front Pharmacol"},{"key":"R11-20260817","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1213\/ANE.0b013e31823f0c28","article-title":"A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): part I. Safety, efficacy, and basic pharmacokinetics.","volume":"115","author":"Antonik","year":"2012","journal-title":"Anesth Analg"},{"key":"R12-20260817","doi-asserted-by":"crossref","first-page":"307","DOI":"10.4097\/kja.22297","article-title":"Remimazolam - current knowledge on a new intravenous benzodiazepine anesthetic agent.","volume":"75","author":"Kim","year":"2022","journal-title":"Korean J Anesthesiol"},{"key":"R13-20260817","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.2147\/DDDT.S474854","article-title":"Remimazolam in general anesthesia: a comprehensive review of its applications and clinical efficacy.","volume":"18","author":"Zhang","year":"2024","journal-title":"Drug Des Devel Ther"},{"key":"R14-20260817","doi-asserted-by":"crossref","first-page":"1409233","DOI":"10.3389\/fmed.2024.1409233","article-title":"Clinical study on the safety and efficacy of remimazolam in hysteroscopic surgery under general anesthesia in elderly patients.","volume":"11","author":"Xie","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"R15-20260817","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/s12871-024-02675-7","article-title":"The influence of sex on the dosage of remimazolam co-administered with remifentanil for loss of consciousness in adult patients: an up-and-down sequential allocation trial.","volume":"24","author":"Oh","year":"2024","journal-title":"BMC Anesthesiol"},{"key":"R16-20260817","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/LBR.0000000000000784","article-title":"Correlation of vital signs and depth of sedation by modified observer\u2019s assessment of alertness and sedation (MOAA\/S) scale in bronchoscopy.","volume":"29","author":"Pastis","year":"2022","journal-title":"J Bronchology Interv Pulmonol"},{"key":"R17-20260817","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/pan.13088","article-title":"Sequential allocation trial design in anesthesia: an introduction to methods, modeling, and clinical applications.","volume":"27","author":"G\u00f6rges","year":"2017","journal-title":"Paediatr Anaesth"},{"key":"R18-20260817","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1213\/ANE.0000000000005011","article-title":"The median effective dose of one intravenous bolus of oxycodone for postoperative analgesia after myomectomy and hysterectomy with local ropivacaine wound infiltration: an up-down dose-finding study.","volume":"131","author":"Yu","year":"2020","journal-title":"Anesth Analg"},{"key":"R19-20260817","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.gie.2015.08.062","article-title":"A phase IIb study comparing the safety and efficacy of remimazolam and midazolam in patients undergoing colonoscopy.","volume":"83","author":"Pambianco","year":"2016","journal-title":"Gastrointest Endosc"},{"key":"R20-20260817","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.gie.2018.04.2351","article-title":"A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy.","volume":"88","author":"Rex","year":"2018","journal-title":"Gastrointest Endosc"},{"key":"R21-20260817","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1186\/s12871-023-02249-z","article-title":"Effects of remimazolam combined with sufentanil on hemodynamics during anesthetic induction in elderly patients with mild hypertension undergoing orthopedic surgery of the lower limbs: a randomized controlled trial.","volume":"23","author":"Xu","year":"2023","journal-title":"BMC Anesthesiol"},{"key":"R22-20260817","doi-asserted-by":"crossref","first-page":"3566","DOI":"10.1097\/JS9.0000000000000638","article-title":"The safety and efficacy between remimazolam and propofol in intravenous anesthesia of endoscopy operation: a systematic review and meta-analysis.","volume":"109","author":"Zhao","year":"2023","journal-title":"Int J Surg"},{"key":"R23-20260817","doi-asserted-by":"crossref","first-page":"7645","DOI":"10.1038\/s41598-024-58294-2","article-title":"Comparison of efficacy and safety of equivalent doses of remimazolam versus propofol for gastroscopy anesthesia in elderly patients.","volume":"14","author":"Chen","year":"2024","journal-title":"Sci Rep"},{"key":"R24-20260817","doi-asserted-by":"crossref","first-page":"1506209","DOI":"10.3389\/fphar.2024.1506209","article-title":"Median effective dose of remimazolam combined with sufentanil for inhibiting laryngeal mask airway insertion responses in children of different ages.","volume":"15","author":"Li","year":"2024","journal-title":"Front Pharmacol"},{"key":"R25-20260817","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/01.anes.0000267514.42592.2a","article-title":"Advances in and limitations of up-and-down methodology: a pr\u00e9cis of clinical use, study design, and dose estimation in anesthesia research.","volume":"107","author":"Pace","year":"2007","journal-title":"Anesthesiology"},{"key":"R26-20260817","doi-asserted-by":"crossref","first-page":"23635","DOI":"10.1038\/s41598-025-08907-1","article-title":"Determination of the median effective dose of sufentanil combined with remimazolam in inhibiting tracheal intubation response.","volume":"15","author":"Feng","year":"2025","journal-title":"Sci Rep"},{"key":"R27-20260817","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12871-021-01373-y","article-title":"Efficacy and safety of remimazolam besylate versus propofol during hysteroscopy: single-centre randomized controlled trial.","volume":"21","author":"Zhang","year":"2021","journal-title":"BMC Anesthesiol"},{"key":"R28-20260817","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1080\/17512433.2021.1919084","article-title":"Pharmacological control of pain during propofol injection: a systematic review and meta-analysis.","volume":"14","author":"Bakhtiari","year":"2021","journal-title":"Expert Rev Clin Pharmacol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050209","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:01:54Z","timestamp":1786982514000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050209"}},"subtitle":["A prospective dose-finding study using Dixon\u2019s up-and-down method"],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":28,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000050209","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,14]]},"assertion":[{"value":"2025-01-24","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-23","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}